KCM
PGNX

Kingdon Capital Management’s Progenics Pharmaceuticals Inc PGNX Stock Holding History

Kingdon Capital Management’s Portfolio PGNX Stock Details PGNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2013
Q3 		– Sell
-580,000
Closed -$2.58M – 218
2013
Q2 		$2.58M Buy
+580,000
New +$2.58M 0.15% 126